Related Experiment Video
Updated: Aug 9, 2026

Mouse Bladder Wall Injection
Published on: July 12, 2011
Inhibition of basic fibroblast growth factor expression, angiogenesis, and growth of human bladder carcinoma in mice
C P Dinney1, D R Bielenberg, P Perrotte
1Department of Cell Biology, The University of Texas M.D. Anderson Cancer Center, Houston 77030, USA.
Abstract:
The purpose of these studies was to determine whether systemic administration of IFN-alpha can inhibit the expression of basic fibroblast growth factor (bFGF) in human transitional cell carcinoma, reduce its angiogenesis, and thus inhibit its growth in the bladder wall of nude mice. In vitro incubation of the highly metastatic 253J B-V cells and the IFN-alpha-resistant 253J B-V IFNR cells with noncytostatic concentrations of IFN-alpha down-regulated the steady-state mRNA transcripts and protein production of bFGF. IFN-alpha-insensitive and IFN-alpha-resistant cells were implanted in the bladder wall of nude mice. Systemic administration of IFN-alpha decreased the in vivo expression of bFGF, decreased blood vessel density in the tumors, and inhibited tumor growth of both IFN-alpha-insensitive and IFN-alpha-resistant cells. These data suggest that in addition to its well-documented antiproliferative effects, IFN-alpha can inhibit the growth of human bladder cancer cells by inhibition of angiogenesis.
Insights
Interferon-alpha (IFN-alpha) inhibits basic fibroblast growth factor (bFGF) and angiogenesis, slowing human bladder cancer growth in mice. This suggests IFN-alpha has anti-angiogenic properties beyond its antiproliferative effects.
Area of Science:
- Oncology
- Immunology
- Molecular Biology
Background:
- Human transitional cell carcinoma exhibits high metastatic potential.
- Basic fibroblast growth factor (bFGF) is implicated in tumor growth and angiogenesis.
- Interferon-alpha (IFN-alpha) is known for its antiproliferative effects.
Purpose of the Study:
- To investigate IFN-alpha's ability to inhibit bFGF expression in human bladder cancer.
- To determine if IFN-alpha reduces tumor angiogenesis.
- To assess the impact of IFN-alpha on bladder tumor growth in vivo.
Main Methods:
- In vitro studies using 253J B-V and IFN-alpha-resistant 253J B-V IFNR cells.
- Exposure to noncytostatic concentrations of IFN-alpha.
- Implantation of cancer cells into the bladder wall of nude mice.
- Systemic administration of IFN-alpha.
Main Results:
- IFN-alpha down-regulated bFGF mRNA transcripts and protein production in vitro.
- Systemic IFN-alpha decreased in vivo bFGF expression.
- IFN-alpha reduced tumor blood vessel density (angiogenesis).
- Tumor growth was inhibited in both IFN-alpha-insensitive and resistant cells.
Conclusions:
- IFN-alpha inhibits human bladder cancer growth through anti-angiogenic mechanisms.
- IFN-alpha reduces bFGF expression and angiogenesis in transitional cell carcinoma.
- These findings add anti-angiogenic effects to the known antiproliferative actions of IFN-alpha.
Related Concept Videos
Regulation of Angiogenesis and Blood Supply
Inhibitors of Viral Protein Synthesis

